Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: A novel antitumor agent?

被引:51
作者
Saltzman, DA
Katsanis, E
Heise, CP
Hasz, DE
Vigdorovich, V
Kelly, SM
Curtiss, R
Leonard, AS
Anderson, PM
机构
[1] UNIV MINNESOTA, DEPT PEDIAT, MINNEAPOLIS, MN 55455 USA
[2] MEGAN ANIM HLTH, ST LOUIS, MO USA
[3] WASHINGTON UNIV, DEPT BIOL, ST LOUIS, MO 63130 USA
[4] MAYO CLIN, DEPT PEDIAT & ADOLESCENT MED, ROCHESTER, MN USA
关键词
avirulent Salmonella; interleukin-2; hepatic malignancy; biotherapy;
D O I
10.1016/S0022-3468(97)90198-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Currently, there is no long-term effective treatment for unresectable hepatic malignancies. Salmonella species are known to naturally track to the liver during active infection. To develop a biological vector for delivery of interleukin-2 (IL-2) to the liver for antitumor purposes, the (chi)4550 attenuated strain of Salmonella typhimurium was used as a vector for IL-2. The gene for human IL-2 was cloned into plasmid pYA292 and inserted into the attenuated S typhimurium and renamed [(chi)4550(pIL-2)]: MCA-38 murine adenocarcinoma cells were injected intrasplenically into C57BL/6 mice to produce hepatic metastases that were subsequently enumerated after 12 days. Wi previously have demonstrated that the (chi)4550(plL-2) produces biologically active IL-2 and that a single gavage feeding of 10(7) (chi)4550(plL-2) significantly reduced the number of hepatic metastases' when compared with animals fed salmonella lacking the IL-2 gene or nontreated controls. The aims of the current studies were to determine which host effector cell populations were responsible for the antitumor effect seen with (chi)4550(plL-2) by depletion of natural killer (NK), cytotoxic T lymphocytes (CD8(+)), T helper (CD4(+)) cells, and Kupffer cells. Multiple experiments were conducted for each host effector cell population depleted. We found a consistent reduction in the mean number of hepatic: metastases in animals fed (chi)4550(pIL-2) (55.6 metastases; n = 54) when compared with controls (162.3 metastases; n = 53) (P <.0001). Depletion of NK cells and CD8(+) T cells significantly inhibited the antitumor effect of (chi)4550(pIL-2) (analysis of variance [ANOVA], P <.01). Elimination of CD4(+) T cells and Kupffer cells had no significant impact on the antitumor effect of (chi)4550(pIL-2) (ANOVA, P value was not significant). Salmonella IL-2 may represent a novel form of in vivo biotherapy for unresectable hepatic malignancies that employs the oral route of administration. Furthermore, both NK cells or CD8(+) cells are required for the antitumor effect seen while CD4(+) T cells and Kupffer cells do not appear to be as essential. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 25 条
[1]   EFFECTS OF ROUTE AND FORMULATION ON CLINICAL PHARMACOKINETICS OF INTERLEUKIN-2 [J].
ANDERSON, PM ;
SORENSON, MA .
CLINICAL PHARMACOKINETICS, 1994, 27 (01) :19-31
[2]   INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR HAVE A ROLE IN TUMOR REGRESSIONS MEDIATED BY MURINE CD8+ TUMOR-INFILTRATING LYMPHOCYTES [J].
BARTH, RJ ;
MULE, JJ ;
SPIESS, PJ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :647-658
[3]  
Blumgart L H, 1995, Curr Probl Surg, V32, P333
[5]   SALMONELLA-TYPHIMURIUM DELETION MUTANTS LACKING ADENYLATE-CYCLASE AND CYCLIC-AMP RECEPTOR PROTEIN ARE AVIRULENT AND IMMUNOGENIC [J].
CURTISS, R ;
KELLY, SM .
INFECTION AND IMMUNITY, 1987, 55 (12) :3035-3043
[6]  
DIALYNAS DP, 1983, J IMMUNOL, V131, P2445
[7]   A SAFE-SITE FOR SALMONELLA-TYPHIMURIUM IS WITHIN SPLENIC CELLS DURING THE EARLY PHASE OF INFECTION IN MICE [J].
DUNLAP, NE ;
BENJAMIN, WH ;
MCCALL, RD ;
TILDEN, AB ;
BRILES, DE .
MICROBIAL PATHOGENESIS, 1991, 10 (04) :297-310
[8]  
ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P1488
[9]   HETEROGENEITY OF RAT-LIVER AND SPLEEN MACROPHAGES IN GADOLINIUM CHLORIDE-INDUCED ELIMINATION AND REPOPULATION [J].
HARDONK, MJ ;
DIJKHUIS, FWJ ;
HULSTAERT, CE ;
KOUDSTAAL, J .
JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (03) :296-302
[10]   A RECOMBINANT SALMONELLA-TYPHIMURIUM VACCINE INDUCES LOCAL IMMUNITY BY 4 DIFFERENT ROUTES OF IMMUNIZATION [J].
HOPKINS, S ;
KRAEHENBUHL, JP ;
SCHODEL, F ;
POTTS, A ;
PETERSON, D ;
DEGRANDI, P ;
NARDELLIHAEFLIGER, D .
INFECTION AND IMMUNITY, 1995, 63 (09) :3279-3286